Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-05-29

FDA Approved: FORMOTEROL FUMARATE — Supplemental Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved a supplemental application for Formoterol Fumarate from Mylan Pharmaceuticals, indicating approval of a supplemental NDA for this product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FORMOTEROL FUMARATE (Formoterol fumarate dihydrate)

Snippet

SUPPL AP for FORMOTEROL FUMARATE (FORMOTEROL FUMARATE DIHYDRATE)